Clinical and lab factors linked to advanced MASH fibrosis in study
Nearly 31.3% of adult patients diagnosed with metabolic dysfunction-associated steatohepatitis examined in an analytical cross-sectional study presented with advanced liver fibrosis. Out of 700 participants who underwent transient elastography using the FibroScan® system for fibrosis assessment, 219 individuals were categorized into the advanced fibrosis group, while the remaining participants fell into the non-advanced group. The … Read more